S86. Vesicular Monoamine Transporter (VMAT2) Binding in Platelets as a Biomarker for Severity of Major Depressive Disorder

      Monoamine neurotransmission has been implicated in major depressive disorder (MDD). Vesicular monoamine transporter-2 (VMAT2) sequesters cytosolic monoamines inside presynaptic vesicles in neurons, as well as in platelets, which can be used as an accessible peripheral model.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect